Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)
/in Chronic Virus Hepatitis, International PublicationsAlterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
/in Breast Cancer, Dendritic Cells, International PublicationsMaximizing dendritic cell migration in cancer immunotherapy
/in Dendritic Cells, International PublicationsStrategies to overcome obstacles to successful immunotherapy of melanoma
/in International Publications, Malignant MelanomaPhase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma
/in International Publications, Malignant MelanomaPhenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
/in International Publications, Malignant MelanomaIFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma
/in International Publications, Malignant MelanomaPhase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
/in International Publications, Malignant MelanomaDendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
/in Dendritic Cells, International Publications, Thyroid Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer